Subscribe
Share
Share
Embed
Covering Fixed Asset Investment, Medical Device, High-Interest Loan, Authorisation, Shortage Prevention. Explore key regulatory updates on Fixed Asset Investment, Medical Devices, High-Interest Loans, Authorisation, and Shortage Prevention across multiple regions, including new guidelines, enforcement actions, and policy proposals.
Regulatory news, updates, and insights presented by the Carver Agents team
Welcome to Carver's regulatory updates podcast for the week of August 09, 2026.
Starting with regulatory developments in Africa, Nigeria’s National Agency for Food and Drug Administration and Control, or NAFDAC, has introduced the 2024 Guidelines for Conformity Assessment of In Vitro Diagnostic Medical Devices. This new framework establishes a harmonized conformity assessment system with defined elements including quality management systems, post-market surveillance, technical documentation, declaration of conformity, and registration requirements tailored to different risk classes of IVD devices. Manufacturers are now required to implement quality management systems appropriate to their device class, establish post-market surveillance processes including complaint handling and vigilance reporting, and prepare technical documentation according to device classification.
Turning to Asia, the Beijing Development and Reform Commission in China has announced the second batch of government fixed asset investment support for new energy heating projects in 2026. The announcement details supported technologies, funding proportions, application requirements, and procedures. Projects must utilize specified new energy heating technologies, meet minimum installed capacity proportions for funding eligibility, be located within Beijing, and comply with ecological, urban planning, and investment regulations.
Also in China, a notice dated August 1, 2026, has been issued regarding the allocation of procurement volumes for selected Chinese patent medicines under the National Chinese Patent Medicine Procurement Alliance. Participating medical institutions are required to use specified platforms and credentials to confirm and submit procurement volume allocations within the set timeframe. Once submitted, data is generally not modifiable, so institutions must ensure accuracy before submission. Local medical insurance departments are tasked with organizing and supervising the process within their jurisdictions.
In Australia, the Australian Competition and Consumer Commission, or ACCC, has proposed not to authorise the Insurance Council of Australia and its members to coordinate on standardised definitions for the terms “taking reasonable steps to maintain” and “wear and tear,” as well as related education campaigns. Stakeholders are invited to submit feedback on this proposal by August 20, 2026.
Moving to the European Union, the Executive Steering Group on Shortages and Safety of Medicinal Products, known as MSSG, held its meeting in July 2026. The group provided updates on the expected publication of new pharmaceutical legislation in December 2026, which will feature staggered application of provisions. Updates included shortage prevention plans, vulnerability assessments, and critical shortages of specific medicines such as Visudyne. Marketing authorisation holders will be required to respond to vulnerability assessments and provide relevant data, adopt and use the updated Shortage Prevention Plan template and guidance, and continue bi-monthly reporting on critical shortages.
In the United States, the Financial Crimes Enforcement Network, or FinCEN, has assessed a historic $125 million civil money penalty against UBS Financial Services Incorporated for repeated violations of the Bank Secrecy Act. The violations include failure to monitor foreign currency wires and inadequate customer due diligence, particularly for high-risk customers connected to Russia and Latin America. UBSFS is required to work with a third party to conduct a lookback to identify and report previously undetected suspicious transactions and undergo an independent review of its anti-money laundering program focused on priority illicit finance risks, including those related to Russia and Latin America.
Also in the United States and Mexico, The Forum on the Colorado River has adopted the draft 2026 Review of Water Quality Standards for Salinity for public comment. Stakeholders are invited to submit written comments by August 31, 2026.
In Malaysia, Mr. Syahrul Imran Mahadzir, Deputy Director-General of the Labuan Financial Services Authority, delivered opening remarks at the 2nd Labuan International Compliance Conference 2026. He highlighted enforcement actions including license revocations, suspensions, and penalties against entities failing to meet anti-money laundering and counter-financing of terrorism requirements. Financial institutions are reminded to maintain minimum capital requirements, submit accurate and timely Statistical Management System reports including AML/CFT forms, and appoint compliance officers or designated compliance officers with sufficient authority.
Back in the United States, on August 6, 2026, Illinois Attorney General Kwame Raoul led a coalition of state attorneys general from Arizona, California, Connecticut, the District of Columbia, Maine, Maryland, Massachusetts, Michigan, Minnesota, New Jersey, New York, North Carolina, Oregon, Rhode Island, Vermont, Virginia, Washington, and Utah. The coalition urged the federal government to deny the merger and national bank charter application of Opportunity Financial, or OppFi. They called on federal regulators to deny OppFi’s application, maintain enforcement of state usury laws and consumer protections, and prevent the expansion of high-cost loans.
Finally, in Brazil, the Comissão de Valores Mobiliários, or CVM, resumed judgment of the case involving former directors of IRB – Brasil Resseguros S.A. The CVM Collegiate decided to absolve Fernando Passos and José Carlos Cardoso from accusations in case PAS 19957.003612/2020-35. Other accused parties in related cases were also absolved. However, penalties were imposed on Américo Maciel de Souza for misconduct. The ruling emphasizes compliance with fiduciary duties and disclosure obligations under Brazilian securities laws and CVM instructions. It also enforces prohibitions and penalties for misuse of client credentials and false reporting. The parties retain the right to appeal with suspensive effect to the Conselho de Recursos do Sistema Financeiro Nacional.
That wraps up today's regulatory updates. Visit carveragents.ai for more information.